Analysts Set Trupanion, Inc. (NASDAQ:TRUP) PT at $51.80

Shares of Trupanion, Inc. (NASDAQ:TRUP) have been given a consensus recommendation of “Moderate Buy” by the seven ratings firms that are covering the firm, Marketbeat reports. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $51.80.

Several research firms have recently commented on TRUP. Stifel Nicolaus lowered their price target on shares of Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research report on Thursday, February 20th. Piper Sandler lowered their price target on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Finally, Lake Street Capital lowered their price target on shares of Trupanion from $65.00 to $60.00 and set a “buy” rating for the company in a research report on Friday, May 2nd.

Insider Activity at Trupanion

In related news, CEO Margaret Tooth sold 2,294 shares of the stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total value of $72,008.66. Following the completion of the transaction, the chief executive officer now owns 118,784 shares in the company, valued at $3,728,629.76. This represents a 1.89% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Brenna Mcgibney sold 5,000 shares of the stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.99, for a total transaction of $164,950.00. Following the completion of the transaction, the insider now owns 3,738 shares of the company’s stock, valued at $123,316.62. This represents a 57.22% decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,792 shares of company stock worth $1,122,802 in the last 90 days. Corporate insiders own 5.50% of the company’s stock.

Hedge Funds Weigh In On Trupanion

Several large investors have recently made changes to their positions in TRUP. Barclays PLC boosted its position in shares of Trupanion by 259.2% during the 3rd quarter. Barclays PLC now owns 65,498 shares of the financial services provider’s stock valued at $2,750,000 after purchasing an additional 47,262 shares in the last quarter. JPMorgan Chase & Co. boosted its position in shares of Trupanion by 2.7% during the 3rd quarter. JPMorgan Chase & Co. now owns 28,317 shares of the financial services provider’s stock valued at $1,189,000 after purchasing an additional 738 shares in the last quarter. Ameritas Advisory Services LLC bought a new position in shares of Trupanion during the 4th quarter valued at about $389,000. Bartlett & CO. Wealth Management LLC bought a new position in shares of Trupanion during the 4th quarter valued at about $266,000. Finally, KBC Group NV bought a new position in shares of Trupanion during the 4th quarter valued at about $75,000.

Trupanion Stock Down 0.7%

Shares of NASDAQ:TRUP opened at $45.43 on Tuesday. The stock has a market capitalization of $1.94 billion, a price-to-earnings ratio of -197.52, a price-to-earnings-growth ratio of 6.02 and a beta of 1.72. Trupanion has a 1-year low of $25.90 and a 1-year high of $57.90. The company’s fifty day moving average is $37.69 and its two-hundred day moving average is $44.39. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.66 and a current ratio of 1.71.

Trupanion (NASDAQ:TRUP) last issued its earnings results on Thursday, May 1st. The financial services provider reported ($0.03) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.05) by $0.02. The company had revenue of $341.98 million for the quarter, compared to analysts’ expectations of $337.81 million. Trupanion had a negative net margin of 0.75% and a negative return on equity of 3.08%. The firm’s revenue was up 11.7% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.16) earnings per share. Equities analysts anticipate that Trupanion will post 0.13 EPS for the current year.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.